Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: RTOG 1119 Principal Investigator: Zoberi, Imran
Title: Phase II Randomized Study of Whole Brain Radiotherapy in Combination with Concurrent Lapatinib in Patients with Brain Metastasis from Her2-Positive Breast Cancer A Collaborative Study of RTOG and KROG
Phase: II Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to compare the effects of adding lapatinib to standard whole brain radiation therapy (WBRT) on you and your cancer. The study will try to find out whether WBRT or lapatinib plus WBRT is better at safely improving tumor control. In this study, you will receive either
lapatinib plus WBRT or WBRT alone.
 
More Information:
ClinicalTrials.gov Entry
Internal Protocol Documents (requires Siteman administrative database password)